Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer.
Melillo
L M
LM
Sajeva
M R
MR
Musto
P
P
Perla
G
G
Cascavilla
N
N
Minervini
M M
MM
D'Arena
G
G
Carotenuto
M
M
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D008937:Mitomycins / Q000009:adverse effects; D008942:Mitoxantrone / Q000009:adverse effects; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
D008937:Mitomycins; D008942:Mitoxantrone; D008727:Methotrexate